APA (7th ed.) Citation

Saliby, R., Machaalani, M., Labaki, C., Jammihal, T., Rout, R., Steiner, C., . . . Choueiri, T. (2025). 2601P Peripheral and tumor cytokines in exceptional responders to immunotherapy: Results from a phase III trial. Annals of Oncology, 36, S1395. https://doi.org/10.1016/j.annonc.2025.08.3217

Chicago Style (17th ed.) Citation

Saliby, R.M, et al. "2601P Peripheral and Tumor Cytokines in Exceptional Responders to Immunotherapy: Results from a Phase III Trial." Annals of Oncology 36 (2025): S1395. https://doi.org/10.1016/j.annonc.2025.08.3217.

MLA (9th ed.) Citation

Saliby, R.M, et al. "2601P Peripheral and Tumor Cytokines in Exceptional Responders to Immunotherapy: Results from a Phase III Trial." Annals of Oncology, vol. 36, 2025, p. S1395, https://doi.org/10.1016/j.annonc.2025.08.3217.